Skip to main content

RA CAPITAL MANAGEMENT, L.P.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1346824 BOSTON, MA

Position in RYTM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$579,814,813
-$133,803,419 QoQ
Shares Held
6,666,837
0.0% QoQ
Ownership
9.73%
of shares outstanding
% of Portfolio
6.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RA CAPITAL MANAGEMENT, L.P. holds $9,134,713,488 across 74 Biotechnology names. RYTM ranks #3 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 RYTM
Rhythm Pharmaceuticals, Inc.
This page
6,666,837 $579,814,813

All Filings in RYTM

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $579,814,813 6,666,837
2025-12-31 $713,618,232 6,666,837
2025-09-30 $573,760,445 5,681,359
2025-06-30 $351,422,275 5,561,359
2025-03-31 $322,291,303 6,084,412
2024-12-31 $340,605,383 6,084,412
2024-09-30 $318,762,344 6,084,412
2024-06-30 $249,825,956 6,084,412
2023-12-31 $245,039,039 5,330,412
2023-06-30 $93,598,344 5,676,067
2023-03-31 $98,406,635 5,516,067
2022-12-31 $160,627,871 5,516,067
2022-09-30 $134,041,141 5,471,067
2022-06-30 $20,214,928 4,871,067
2022-03-31 $56,114,691 4,871,067
2021-12-31 $48,613,248 4,871,067
2021-09-30 $63,616,135 4,871,067
2021-06-30 $95,375,491 4,871,067
2021-03-31 $103,607,595 4,871,067
2020-12-31 $124,243,661 4,179,067
2020-09-30 $111,392,641 5,140,408
2020-06-30 $116,184,962 5,210,088
2020-03-31 $82,527,588 5,422,312